IceCure Medical Showcases ProSense Cryoablation Data at RSNA 2025 Annual Meeting
I'm PortAI, I can summarize articles.
IceCure Medical showcased its ProSense cryoablation technology for breast cancer treatment at the RSNA 2025 Annual Meeting in Chicago. Four independent studies highlighted the effectiveness and adoption of this minimally-invasive system as an alternative to surgical tumor removal. The event attracted 50,000 attendees from 160 countries, emphasizing advancements in radiology and cancer care.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments